Worldwide Blood Collection Tubes for Liquid Biopsy Industry to 2028 – Rise in Demand for Minimally Invasive Diagnostic Tests is Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Blood Collection Tubes for Liquid Biopsy Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product, Material, Application , End User” report has been added to ResearchAndMarkets.com’s offering.

The blood collection tubes for liquid biopsy market is projected to reach US$ 256.26 million by 2028 from US$ 79.03 million in 2021.

It is estimated to grow at a CAGR of 18.3% from 2021 to 2028. Factors such as an increase in the prevalence of cancer and rising demand for minimally invasive diagnostic tests are boosting the blood collection tubes for liquid biopsy market growth. However, the lack of skilled professionals leading to inaccurate blood collection for liquid biopsy analysis hampers the market growth.

The blood collection tubes are used for the collection and storage of blood samples for a prolonged time. These tubes provide precision, accuracy, speed, safety, and ease of use during diagnostic procedures, such as liquid biopsy. A liquid biopsy is a noninvasive or a minimally invasive alternative to surgical biopsies that allows doctors to learn tumors in depth by performing certain tests on their blood samples. Cancer DNA traces in the blood can reveal the most suitable treatment for a given patient. The development of numerous specialized measurement techniques have resulted into novel diagnostics such as circulating cell free DNA analysis. . Over the last few years, there has been a surge in interest in the (pre-)analytical conditions associated with the liquid biopsy workflow.

Based on product, the blood collection tubes for liquid biopsy market is segmented as Ccf DNA tubes, CfRNA tubes, CTC tubes, GDNA tubes, intracellular RNA tubes, and others. Based on material, the market is segmented into glass and plastic. Furthermore, the blood collection tubes for liquid biopsy market, by application, is segmented into in-vitro diagnostics and research. On the basis of end-user, the blood collection tubes for liquid biopsy is segmented as genetic diagnostic labs, R&D centers, conventional diagnostic centers, and others.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the blood collection tubes for liquid biopsy market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the global blood collection tubes for liquid biopsy market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Market Dynamics

Drivers

• Increase in Prevalence of Cancer Worldwide
• Rise in Demand for Minimally Invasive Diagnostic Tests

Restraints

• Lack of Skilled Professionals Leading to Inaccurate Blood Collection for Liquid Biopsy Analysis

Opportunities

• Untapped Potential of Emerging Economies

Future Trends

• Technological Advancements in Blood Collection Tubes for Liquid Biopsy

Companies Mentioned

• PreAnalytix GmbH
• Biocept,Inc.
• F. HOFFMANN-LA ROCHE LTD
• STRECK
• Norgen Biotek Corp
• Exact Sciences Corporation
• Greiner AG
• MagBio Genomics, Inc.
• Zymo Research Corporation
• Apostle Sciences

For more information about this report visit https://www.researchandmarkets.com/r/7zbmwp

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900